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Immune function during early adolescence positively predicts adult facial sexual 
dimorphism in both men and women  
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Abstract 
Evolutionary theories suggest that humans prefer sexual dimorphism in faces because 
masculinity in men and femininity in women may be an indicator of immune function during 
development. In particular, the immunocompetence handicap hypothesis proposes that sexual 
dimorphism indicates good immune function during development because the sex hormones, 
particularly testosterone in men, required for the development of sexually dimorphic facial 
features also taxes the immune system. Therefore, only healthy males can afford the high 
level of testosterone for the development of sexually dimorphic traits without compromising 
their survival. Researchers have suggested that a similar mechanism via the effects of 
estrogen might also explain male preferences for female femininity. Despite the prominence 
of the immunocompetence handicap hypothesis, no studies have tested whether immune 
function during development predicts adult facial sexual dimorphism. Here, using data from a 
longitudinal public health dataset, the Western Australian Pregnancy Cohort (Raine) Study 
(Generation 2), we show that some aspects of immune function during early adolescence (14 
years) positively predict sexually dimorphic 3D face shape in both men and women. Our 
results support a fundamental assumption that facial sexual dimorphism is an indicator of 
immune function during the development of facial sexual dimorphism.  
 
Key words: sexual dimorphism, immunocompetence handicap hypothesis, facial 
attractiveness   
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1. Introduction 
Men and women differ in their facial appearance. Men have more prominent brow 
ridges, stronger jawlines, more prominent cheekbones, and thinner lips compared to women 
(D. M. Enlow, 1982). Noting the highly elaborate sexually dimorphic traits found in many 
species, Darwin proposed that secondary sexual traits could have evolved via sexual selection 
for two main purposes: attracting the opposite sex (mate choice) and/or competing with 
same-sex conspecifics for access to opposite-sex partners (mating competition) (Darwin, 
1871). Since the inception of the theory of sexual selection, mate choice for sexually 
dimorphic traits has been demonstrated in a wide range of taxa, including insects, fishes, 
birds, reptiles, and mammals (Andersson, 1994). In humans, there is considerable evidence 
that facial sexual dimorphism (i.e. masculinity in men and femininity in women) is linked to 
attractiveness in both sexes (Foo, Simmons, & Rhodes, 2017; Holzleitner & Perrett, 2017; 
Little, Jones, & DeBruine, 2011; Rhodes, 2006; Thornhill & Gangestad, 1999). Across 
studies, masculinity in men has been found to elicit a range of preferences that depend on 
factors such as mating context (short-term vs long-term mating), the women’s own 
attractiveness and partner violence (Borras-Guevara, Batres, & Perrett, 2017; Li et al., 2014; 
Little et al., 2011; Rhodes, 2006; Scott, Clark, Boothroyd, & Penton-Voak, 2013). Variation 
in preferences for masculinity have often been interpreted in terms of balancing the pros of 
having a high-quality man against the increased likelihood of partner violence and 
unfaithfulness (Little et al., 2011). In contrast, femininity in women has consistently been 
found to be preferred by men (Little et al., 2011; Rhodes, 2006). Overall, a meta-analysis 
showed that both men and women with more sexually dimorphic faces are rated by the 
opposite sex as more attractive than their less sexually dimorphic counterparts (Rhodes, 
2006). Facial sexual dimorphism is also positively related to self-reported mating success in 
both sexes (Rhodes, Simmons, & Peters, 2005). Together, the evidence indicates that sexual 
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selection via mate choice may have played a role in the evolution of facial sexual dimorphism 
in humans. But why have we evolved to prefer facial sexual dimorphism in opposite-sex 
partners? 
One prominent theory is that sexually dimorphic traits provide honest indicators of 
quality, particularly immune function (Folstad & Karter, 1992; Hamilton & Zuk, 1982). 
Individuals are exposed to pathogens on a daily basis. Some pathogens can cause serious 
infections that threaten our health or even survival. Indeed, data from the World Health 
Organization (WHO) show that disease-causing infections such as lower respiratory 
infections, diarrhoeal diseases, and tuberculosis are among the top ten causes of mortality in 
humans (World Health Organization, 2018). In response to the debilitating effects of 
infectious diseases, our immune system has evolved a complex range of defences to 
neutralize pathogens (Parkin & Cohen, 2001). From a sexual selection perspective, therefore, 
choosing a partner based on indicators of superior immunity can provide us with a number of 
direct benefits, including infectious disease avoidance, better parenting, and more resources, 
and indirect benefits such as genes that code for good immune functioning for our offspring 
(Andersson, 1994; Andersson & Simmons, 2006).  
In terms of the mechanistic links, life history theory has proposed that sexually 
dimorphic traits honestly indicate superior immune function because individuals are subject 
to trade-offs in the allocation of limited resources to developing attractive traits vs 
maintaining immune functioning (Rolff, 2002; Stearns, 1977, 1992; Wedekind & Folstad, 
1994). Therefore, healthy individuals with superior immunity can afford to allocate more 
resources to develop highly sexually dimorphic traits. According to the immunocompetence 
handicap hypothesis, in vertebrates, the trade-off in developing sexually dimorphic traits vs 
maintaining immune functioning in males is mediated partly by the immunosuppressive 
effect of the sex hormone testosterone (Folstad & Karter, 1992). Indeed, results from a recent 
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meta-analysis using data from 38 species supported the assumption of the 
immunocompetence handicap hypothesis that testosterone suppresses the immune system in 
males (Foo, Nakagawa, Rhodes, & Simmons, 2017).  
Despite the prediction of the immunocompetence handicap hypothesis, researchers 
have found mixed support for a relationship between facial masculinity and immune function 
in men. Early studies relied primarily on indirect and non-physiological measures of potential 
immune function. For instance, men with masculine faces report experiencing fewer 
infection-related conditions (e.g. flu incidence and antibiotic intake, Thornhill & Gangestad, 
2006; but see Boothroyd, Scott, Gray, Coombes, & Pound, 2013) and are rated by doctors as 
healthier during adolescence based on their past medical records (Rhodes, Chan, Zebrowitz, 
& Simmons, 2003). More recent studies have utilised putative genetic correlates of immune 
function. One example is the degree of heterozygosity in the major histocompatibility 
complex (MHC) genes, which predicts the range of antigens that the immune system can 
recognize (Apanius et al., 2017). MHC heterozygosity was shown not to be linked to facial 
masculinity in men (Lie, Rhodes, & Simmons, 2008; Zaidi et al., 2019). However, MHC 
heterozygosity only measures the range of pathogens to which one can raise a response and 
not the magnitude of the actual response (e.g. the amount of circulating immune 
cells/antibodies or those produced in response to a threat), which is a key aspect of 
eliminating foreign antigens. Few studies have used physiological markers of immune 
function, such as adaptive immunity (Rantala et al., 2013), innate immunity (Foo, Simmons, 
et al., 2017), or cytokine responses to antigen challenges (Phalane, Tribe, Steel, Cholo, & 
Coetzee, 2017). Among these studies, Rantala et al. (2013) and Phalane et al. (2017) found 
support for an association between masculinity and immune function but Foo et al. (2017) did 
not.  
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Although the immunocompetence handicap hypothesis was initially proposed to 
explain the attractiveness of masculine traits in males, researchers have raised the possibility 
that feminine traits may also serve as honest indicators of immune function in females, 
particularly in humans, where both female and male mate choice occur (Gray & Boothroyd, 
2012; Jones, 2018; Rhodes et al., 2003). It was further speculated that a similar trade-off 
mechanism via the effects of the female hormone oestrogen might underpin the relationship 
between facial femininity and immune function in women (Rhodes et al., 2003). However, 
extending the analogy from men’s to women’s faces is questionable for two reasons. First, 
much of the pubertal facial changes that lead to sexual dimorphism (e.g. brow, jaw, 
cheekbones, except the lips), occur in men while women’s faces remain relatively immature 
(D. H. Enlow & Hans, 1996; D. M. Enlow, 1982). Second, a meta-analysis by Foo et al 
(2017) found that oestrogen could have either a positive or negative effect on female immune 
function, depending on the aspect of the immune system measured. Such mixed findings call 
into question the hypothesis that attractive feminine traits honestly indicate female immune 
function because oestrogen suppresses female immune function. Indeed, the relationship 
between facial femininity and immune function in women is mixed. While women with 
feminine faces have lower self-reported prevalence of infection-related conditions (Gray & 
Boothroyd, 2012), studies have failed to find significant relationships between facial 
femininity in women and their adolescent health as rated by doctors (Rhodes et al., 2003), 
MHC genetic heterozygosity (Lie et al., 2008), innate immunity (Foo, Simmons, et al., 2017), 
or salivary IgA levels (Cai et al., 2019). 
The majority of the abovementioned studies have focused on the relationship between 
facial sexual dimorphism and current adult immune function. In general, theories of sexual 
signalling predict a positive relationship between sexual dimorphism and current adult 
immune function. Particularly, under direct-benefit models of mate choice, we expect a 
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positive relationship because we obtain direct benefits (e.g. infectious disease avoidance, 
better parenting, and more resources) only when an attractive partner also has a better 
immunity compared to a less attractive individual (Andersson & Simmons, 2006). However, 
under indirect-good-genes models, trade-offs can lead to null or even negative relationships 
between facial sexual dimorphism and current adult immune function, which could explain 
the mixed findings in the current literature (Getty, 2006). 
Rather than indicating current adult immune function, life-history theory predicts that 
sexually dimorphic traits should indicate immune function during the period in which they 
develop. In many species, secondary sexual traits do not develop until the individuals 
approach sexual maturity (Birkhead, Fletcher, & Pellatt, 1999; D. M. Enlow, 1982; Fry, 
2006; Gilbert, Karp, & Uetz, 2016). In humans, for instance, individuals experience 
substantial development during puberty in facial sexually dimorphic traits, especially shape 
features like the brow ridges, jawlines, cheekbones, and lips (D. M. Enlow, 1982). In such 
species, we expect adult secondary sexual traits to indicate the ability to divert resources to 
the formation of attractive traits while remaining able to cope with parasitic challenges during 
development. This prediction is well-supported in non-human animal studies, with findings 
linking adult male secondary traits to various aspects of juvenile health such as diet and 
immune function in taxa such as insects, fishes, and birds (Geary, 2015; Irschick, Briffa, & 
Podos, 2015).  
Critically, this developmental prediction has received very little empirical attention in 
the human literature, primarily due to the difficulty of conducting protracted longitudinal 
studies to test the relationship between immune function during the period in which 
secondary sexual traits develop (i.e. adolescence) and facial sexual dimorphism in adulthood. 
So far, only one study has done so (Rhodes et al., 2003). In line with the developmental 
prediction, men who were rated by doctors as healthier during adolescence based on their 
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past medical records had more masculine faces in adulthood. The study also tested women 
but failed to find any relationship between adolescent health and adult facial femininity. The 
health data in that study was based on data from the 1920s, before population health was 
impacted by the adoption of modern medical advances such as vaccinations and antibiotics. 
Therefore, the measure is likely to reflect in part the ability to resist pathogens. However, it 
remains plausible that the measure also captured variation in other facets of health, such as 
reproductive or even mental health.  
Here, using data from a large-scale (N > 400) longitudinal public health dataset, the 
Western Australian Pregnancy Cohort (Raine) Study (Straker et al., 2017), we examine the 
relationship between early adolescent immunity and adult facial sexual dimorphism in both 
men and women. The Raine Study was established between 1989-1991 initially with a 
sample of 2900 pregnant women that was representative of the general (Perth) Australian 
community for the purpose of testing the effect of repeated ultrasound scans on pregnancy 
outcomes. Multiple follow-ups with the offspring of participants (i.e. Generation 2) involving 
detailed assessments of health, lifestyle, and family background have since been conducted at 
1, 2, 3, 5, 14, 17, 18, 20 and 22 years of age, providing an invaluable opportunity for testing 
the developmental prediction. Based on life history theory, we hypothesize that immune 
function during development (i.e. adolescence) positively predicts sexual dimorphism in 3D 
facial shape in both men and women. 
Besides providing valuable developmental data for us to test our hypothesis, this 
dataset has two other advantages. First, it contains more than 40 immune physiological 
markers. Generally, evolutionary studies on the links between sexually-selected traits and 
immune function have relied on small number of immune measures. However, the immune 
system is a highly complex collection of mechanisms that work in tandem to protect against 
pathogens (Parkin & Cohen, 2001). Therefore, when studying the immune system, it is 
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crucial to employ multiple measures that index different aspects of immunity (Blount, 
Houston, Møller, & Wright, 2003; Demas & Nelson, 2012; Møller & Petrie, 2002; Norris & 
Evans, 2000; Nowak, Pawłowski, Borkowska, Augustyniak, & Drulis-Kawa, 2018). Here, 
our immune measures include white blood cell counts, generic and antigen-specific 
antibodies, inflammatory markers, and cytokine responses. Together, these measures cover a 
wide range of functional aspects of both innate and adaptive immunity, including anti-
bacterial immunity, anti-viral immunity, cellular immunity, inflammation, and allergies. The 
richness of the immune dataset allows us to provide one of the most comprehensive tests of 
the relationship between immune function and facial sexual dimorphism to date. Second, the 
participants from the Raine dataset are representative of the wider (Perth) Australian 
community (Straker et al., 2017), which increases the generalizability of the results compared 
to previous studies in the field, which have typically been conducted with university student 
samples.  
2. Methods 
 2.1 Participants 
We used the 14-year immune function and 22-year 3D face scans data from 454 
Caucasian Generation 2 participants (218 men and 236 women) from the Raine Study. The 
majority of participants in the dataset had parents who were both self-reported Caucasians 
(82.6%). We decided a-priori to exclude the data of participants who had at least one self-
reported non-Caucasian parent to control for potential racial differences in immune function 
and face shape.  
 2.2 Ethics statement 
The current research was approved by the Human Ethics Committee at the [omitted 
for blind review]. The 14-year follow-up was approved by the Human Ethics Committee of 
[omitted for blind review], and parents provided informed consent, with assent provided by 
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the teenage participants. The 22-year follow-up was approved by the Human Research Ethics 
Committees at the [omitted for blind review] and [omitted for blind review], and informed 
consent was provided by the adult participants. 
 2.3 Immune function at 14 years old 
The teenage participants were visited in their homes by a phlebotomist/enrolled nurse 
to collect early-morning fasting blood and urine samples from the participants. The following 
immune measures were assessed from the blood samples: 
2.3.1 Hematology. A full white blood cell count, including circulating eosinophil, 
lymphocyte, neutrophil, monocyte, and basophil, was conducted.  
2.3.2 Antibodies. Total IgE, IgE to a panel of common inhalant allergens (i.e. 
phadiatop IgE), and IgE to a mixture of SA enterotoxins (SAE) (Staphylococcal enterotoxin 
A, Staphylococcal enterotoxin B and toxic shock syndrome toxin 1) were measured in serum 
using the ImmunoCAP assay (Phadia AB, Uppsala, Sweden).  
IgE, IgG1, and IgG4 antibodies to outer membrane protein P4 and P6 from H influenza, 
and PspA1, PspA2 and PspC from S pneumoniae were assayed by a microtitre plate 
dissociation-enhanced immunofluorescence assay (DELFIA) using humanised chimeric 
antibodies for absolute quantitation.  
2.3.3 Cytokine responses. Peripheral blood mononuclear cells were cultured and 
stimulated with house dust mites, rye, phytohemagglutinnin, poly(I:C), and LPS both with 
and without IFN-γ. IL-5, IL-10, IL-12, IL-13, IFN-γ, and tumor necrosis factor-α responses 
were measured by time-resolved fluorometry as a difference from unstimulated control. IL-4 
and IL-9 responses were measured by quantitative mRNA reverse-transcriptase polymerase 
chain reaction as a difference from unstimulated control.  
2.3.4 Inflammatory marker. The inflammatory marker soluble CD14 was measured 
in plasma by ELISA (BioScientific, Gymea, Australia). 
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The inflammatory eosinophil product eosinophil protein X was measured from urine 
and normalized against creatinine using ELISA (Cayman Chemical, Ann Arbor, MI; Phadia 
AB). Full details of the immune assays were presented in Hollams et al (Hollams et al., 2009) 
 
 2.4 3D shape sexual dimorphism at 22 years old 
3D facial photographs of the participants were taken at the 22-year follow-up using the 
3dMDFace system (www.3dMD.com). Participants were seated at a fixed distance from the 
camera system. The height of the participants’ heads was standardized by adjusting the height 
of their chair such that the participants were at eye-level to a fixed point on the wall in front 
of them. Participants were asked to look straight and keep a neutral expression with their 
mouth closed. The 454 faces in this study represent a subset of an initial pool of 930 faces. 
We selected faces based on the following a-priori inclusion/exclusion criteria: (1) No excess 
facial hair that might obstruct the quantification of face shape (e.g. full beard); (2) No 
excessive missing regions that would prevent quantification of face shape (e.g. missing the 
entire jaw); (3) Neutral expression with mouth closed, eyes open and looking straight at the 
camera; (4) Caucasian; (5) Had immune data from the 14-year follow-up. 
We quantified 3D shape sexual dimorphism using a well-established geometric 
morphometric method in the program Morphanalyser 2.4 (Cai et al., 2019; Holzleitner & 
Perrett, 2017). Twenty-four of the faces (17 men and 7 women) were missing regions of their 
foreheads due to technical reasons (e.g. occlusion by hair or faulty scans) and a minority of 
men were exhibiting signs of receding hairline due to male pattern baldness. Therefore, in 
order to maximise statistical power and avoid confounds in forehead shape due to male 
pattern baldness, we trimmed the forehead from all faces and analysed face shape using only 
the region starting from the brow ridge and downwards. We also trimmed away the neck 
from the face scans to prevent variations in the neck from confounding our face shape 
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measurements. We delineated the xyz positions of 48 landmarks on the faces (see Figure 1 for 
an example. The example depicts the average of all the faces in our dataset and does not 
correspond to any individual identity. Other studies using this method have used similar 
numbers of landmarks (Cai et al., 2019; Holzleitner & Perrett, 2017). The original faces each 
contain different numbers of tessellations. In order for us to make systematic comparisons 
across the faces, we resampled the surface maps in reference to that of one of the faces such 
that all faces contained the same number of tessellations between landmarks. To ensure that 
our sexual dimorphism measure was capturing variations in shape only, Procrustes alignment 
was applied to the resampled surface maps to standardize their size, position in space, tilt, 
and orientation. Size of the head is sexually dimorphic, with men having bigger heads than 
women. However, the size of the head is highly correlated with body size. Therefore, we 
removed variation in face size using the Procrustes alignment to control for size variations 
due simply to magnification. This method maintains allometric shape differences between 
male and female faces (i.e. shape changes arising due to size changes) despite removing 
geometric size. Such procedures are commonly adopted in studies of face shape (Cai et al., 





Figure 1. Example face landmark placements. Example here depicts the average of all the 
faces in our dataset, including both men and women, and does not correspond to any 
individual identity.  
 
Principal components analysis (PCA) was then conducted on the surface maps (i.e. the 
entire network of tessellations, not just the landmarks). Forty PCs were retained (eigenvalue 
> 1). To determine which of these 40 PCs were sexually dimorphic, we conducted 
independent samples t-tests with sex as the independent variable on the 40 PCs. 12 were 
significantly different based on the criterion of p < 0.05. Therefore, we computed a composite 
3D shape sexual dimorphism score (hereafter termed sexual dimorphism) for each face by 
summing the standardized Z scores on the 12 sexually dimorphic PCs weighted by the 
relative contribution of each PC to the overall variance in face shape. The higher the score, 
the more masculine is the shape of the face. To facilitate ease of interpretation, women’s 
sexual dimorphism score was reverse-scored such that a higher score indicated more 
feminine face shape in women. Given the lack of a large and separate training set for deriving 
face shape components that are sexually dimorphic, there is a possibility that some of the sex 
differences are due to idiosyncratic differences arising from our sample. However, given the 
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relatively large number of individuals tested in both sexes (218 men and 236 women) and 
findings that our sample is representative of the larger Perth community on other health and 
life-history variables (Straker et al., 2017), we believe that the contributions of such 
idiosyncrasies to the sexual dimorphism score are likely to be small. 
To confirm that our composite score was indeed capturing variations in sexual 
dimorphism, we entered the score into a discriminant analysis with sex as the classifying 
criterion. Our composite score correctly classified 80.8% of individuals, Wilks' λ = 0.57, χ2 
(1) = 255.71, p < 0.0001 (see Figure 2 for density plot of sexual dimorphism score by sex and 







Figure 2. Density plot of 3D shape facial sexual dimorphism scores by sex of participants. 
Vertical lines denote the average sexual dimorphism score for each sex with the average face 
of the sexes presented above the lines (Mean sexual dimorphism score = -87.85 for women 























Table 1 presents the descriptive statistics.   
 
Table 1. Descriptive statistics of facial sexual dimorphism and immune function by sex of participants (note that the facial femininity scores 
were reversed-scored from the sexual dimorphism scores to facilitate interpretation, i.e. higher score, more feminine). 
  Men   Women 
  N Mean SD Skew Kurtosis   N Mean SD Skew Kurtosis 
Masculinity/Femininity at 22-year follow-up  218 95.11 110.93 -0.42 1.30 
 
236 87.85 99.12 0.02 0.15 
            
Immune function at 14-year follow-up 
           
            
Antibodies 
           
Total IgE (kU/L) 218 247.14 531.16 5.77 44.23 
 
236 214.01 452.34 6.67 64.39 
Phadiatop (common inhalant allergens) IgE 
(PAU/L) 
218 18.39 41.42 4.28 23.30 
 
236 16.01 45.68 5.60 39.92 
Strep. enterotoxin A IgE (kUA/L) 218 0.60 2.28 9.19 102.05 
 
236 0.33 0.98 6.65 47.07 
Outer membrane protein P4 from H. influenzae 
IgE (ng/ml) 
218 0.27 0.66 4.86 31.12 
 
236 0.44 1.39 9.67 118.44 
Outer membrane protein P6 from H. influenzae 
IgE (ng/ml) 
218 0.47 0.88 3.81 19.75 
 
236 0.66 1.41 6.11 54.40 
Pneumococcal surface protein C (PspC) IgE 
(ng/ml) 
218 0.88 1.66 4.17 23.00 
 
236 0.93 1.44 3.37 18.22 
P4 IgG1 (ng/ml) 218 102742.05 664524.92 10.09 107.16 
 
236 239916.12 1653246.22 9.12 89.44 
P6 IgG1 (ng/ml) 218 5749.28 24699.69 7.99 70.42 
 
236 6519.46 23098.80 6.84 57.96 
Pneumococcal surface protein A family 1 of S. 
pneumoniae (PaspA1) IgG1 (ng/ml) 
218 147732.07 258428.08 2.44 6.36 
 
236 96394.77 279224.77 5.89 45.51 
Pneumococcal surface protein A family 2 of S. 
pneumoniae (PaspA2) IgG1 (ng/ml) 
218 353097.71 580535.54 4.92 41.54 
 
236 313006.56 577234.78 3.39 14.99 
PaspC IgG1 (ng/ml) 218 424497.94 584243.50 3.47 20.59 
 
236 476478.16 956491.11 4.99 30.87 
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P4 IgG4 (ng/ml) 218 69.71 224.62 6.74 56.65 
 
236 88.58 377.16 6.55 44.30 
P6 IgG4 (ng/ml) 218 106.37 525.14 7.45 61.87 
 
236 180.76 1119.19 9.82 110.24 
PaspA1 IgG4 (ng/ml) 218 644.56 7301.20 14.50 212.53 
 
236 87.39 485.70 7.92 66.35 
PaspA2 IgG4 (ng/ml) 218 190.49 1121.96 10.41 123.37 
 
236 108.90 620.93 12.22 165.84 
PaspC IgG4 (ng/ml) 218 139.08 306.30 2.81 7.63 
 
236 177.76 391.43 2.55 5.56 
            
Inflammatory markers 
           
Soluble CD14 (SCD14; ng/ml) 218 1858.48 373.98 1.12 2.15 
 
236 1873.27 366.30 0.63 0.94 
Urinary Eosinphil Protein X (EPX; µg/mmol 
Creatinine) 
211 90.92 56.08 1.66 3.12 
 
220 58.36 36.84 2.77 14.68 
            
White blood cell counts            
Eosinophil (x109/L) 218 0.34 0.28 2.98 13.22 
 
234 0.32 0.26 1.99 4.35 
Lymphocyte (x109/L) 218 2.47 0.60 0.59 0.73 
 
234 2.68 0.67 0.71 1.04 
Neutrophil (x109/L) 218 2.74 1.14 5.00 46.09 
 
234 3.24 1.16 0.78 0.96 
Monocyte (x109/L) 218 0.56 0.16 0.92 1.75 
 
234 0.55 0.18 0.80 1.15 
Basophil (x109/L) 218 0.07 0.04 -0.85 -0.72 
 
234 0.08 0.05 -0.25 1.66 
            
Cytokine responses to house dust mite            
IL-5 (pg/ml) 218 13.76 39.70 4.15 20.09 
 
236 11.71 36.18 4.15 20.32 
IL-10 (pg/ml) 218 4.43 14.23 4.67 30.77 
 
236 4.09 11.74 3.11 10.29 
IL-13 (pg/ml) 218 41.48 90.65 5.23 41.24 
 
236 39.23 90.53 5.51 44.74 
Interferon γ (IFNγ; pg/ml) 218 8.50 48.06 10.22 120.61 
 
236 8.43 36.78 8.10 82.66 
            
Cytokine responses to rye            
IL-5 (pg/ml) 218 2.32 9.73 4.48 20.73 
 
236 1.47 8.48 6.75 51.17 
IL-10 (pg/ml) 218 28.03 54.75 4.38 29.29 
 
236 26.64 51.38 4.01 25.57 
IL-13 (pg/ml) 218 17.21 49.43 4.77 27.18 
 
236 14.92 36.84 3.83 19.03 
IFNγ (pg/ml) 218 16.08 79.84 7.97 72.51 
 
236 39.46 342.79 10.67 114.05 
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Cytokine responses to phytohaemagglutinin (PHA)            
IL-5 (pg/ml) 218 224.24 196.76 2.61 10.13 
 
236 208.58 178.24 2.54 9.53 
IL-10 (pg/ml) 218 519.11 371.70 1.69 4.46 
 
236 591.77 394.56 1.03 1.09 
IL-13 (pg/ml) 218 1414.05 782.59 1.47 3.43 
 
236 1320.33 834.87 2.42 11.80 
IFNγ (pg/ml) 218 12187.73 10335.42 2.40 9.62 
 
236 12558.43 9199.67 1.48 3.11 
            
Cytokine responses to staph. enterotoxin B (SEB)            
IL-5 (pg/ml) 218 182.68 153.54 2.44 9.17 
 
233 152.65 121.27 2.66 11.09 
IL-10 (pg/ml) 218 610.74 439.12 2.15 7.80 
 
233 636.59 381.12 1.24 2.45 
IL-13 (pg/ml) 218 820.32 489.66 1.71 4.64 
 
233 756.14 411.94 1.09 1.90 
IFNγ (pg/ml) 218 23830.78 12945.11 0.91 1.03 
 
233 22156.68 12262.71 0.99 1.47 
            
Innate cytokine responses            
IL-10 to lipopolysaccharide (LPS; pg/ml) 217 1039.35 663.37 2.38 12.30 
 
234 1042.09 641.46 1.04 1.23 
IFNγ to LPS (pg/ml) 217 221.37 431.17 6.47 59.13 
 
234 148.60 261.82 4.85 29.43 
Tumour necrosis factor α (TNFα) to LPS (pg/ml) 217 1117.76 676.64 1.33 2.20 
 
234 905.28 684.43 1.64 2.87 
IL-10 to LPS+IFNg (pg/ml) 217 393.00 240.85 1.65 4.12 
 
233 420.54 289.14 1.94 5.93 
IL-12 to LPS+IFNg (pg/ml) 218 639.20 692.83 3.73 21.45 
 
231 545.00 541.62 2.25 6.08 
TNFα to LPS+IFNg (pg/ml) 217 3764.42 1932.38 1.25 2.50 
 
233 3050.14 1730.41 1.18 1.50 
IL-10 to Poly I:C (pg/ml) 217 1736.37 1266.49 1.35 1.90 
 
233 1784.20 1210.01 1.45 2.97 
IFNγ to Poly I:C (pg/ml) 217 1955.91 1952.31 2.09 5.97 
 
233 1542.87 1393.17 1.71 3.20 
TNFα to Poly I:C (pg/ml) 217 842.03 571.81 1.66 5.25   233 687.92 547.71 1.63 2.85 
            
 19 
 3.1 The relationship between immune function and facial masculinity in men 
3.1.1 Male immune data reduction. PCA with varimax rotation was used to 
summarize the interrelated immune function measures in the male data. Sixteen PCs were 
retained (eigenvalue > 1), accounting for 73.49% of the total variance. The factor loadings of 
the PCs are presented in Supplementary Table 1. The PCs were loaded by immune measures 
that measured similar aspects of the immune system or reactions to the same antigen, 
suggesting that our PCA succeeded at identifying clusters of related measures. 
3.1.2 Immune predictors of facial masculinity in men. To identify the immune PCs 
that predicted male facial masculinity, we conducted an Akaike Information Criterion (with 
sample size correction; AICc) based model selection and averaging procedure (Burnham & 
Anderson, 2002; Grueber, Nakagawa, Laws, & Jamieson, 2011; Symonds & Moussalli, 
2011) using the R package MuMIn (Barton, 2014). This analysis was conducted using only 
participants with complete data (i.e. no missing data) to ensure that the AICc values of the 
candidate models generated for selection were comparable. We first generated a list of 
candidate linear regression models that covered all possible combinations of the 16 immune 
function PCs predicting facial masculinity in men. Next, we identified the “best” model based 
on the lowest AICc value. We then averaged the model coefficients (without shrinkage) of all 
models that were within two AICc values from the “best” model and were, therefore, 
considered comparable in terms of model fit. The Information Theoretic Akaike Information 
Criterion (IT-AIC) model selection and averaging approach allows us to compare the 
information value of multiple models and make conclusions based on multiple models that 
are similar in information value simultaneously (Burnham & Anderson, 2002; Grueber et al., 
2011; Symonds & Moussalli, 2011). The model-averaged results also have the advantage of 
being more stable than those derived from just the best model or full model (Richards, 2005; 
Richards, Whittingham, & Stephens, 2011).  
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Visual examination of the scatterplots of facial masculinity in men and each of the 16 
immune PCs revealed that the linear regression models might be influenced by potential 
outliers on immune PCs 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 16 (Supplementary figure 1). 
Therefore, we winsorized all immune PCs to ±4SDs before conducting the model selection 
and averaging. The zero-order correlations between facial masculinity and each of the 
individual immune PCs after winsorization are presented in Supplementary Table 2.  
Thirty models, including the “best” model and 29 others that were within two AICc 
values from the “best” model, were selected from a total of 65535 models. The “best” model 
was 7.98 AICc points lower than the null model, AICcs = 2575.26“best” model vs 2583.24null 
model, indicating that even the least informative model that was selected was a better fit 
compared to the null model based on the criterion of two of more AICc points lower than the 
null (Burnham & Anderson, 2002). This result indicated that the averaged model was indeed 
more informative than the null model. Evidence ratios of the selected models relative to the 
null (i.e. how many times more likely the model results are relative to the null) ranged from 
19.9 to 54.1.  
We tested our hypothesis based on the parameter estimates of the averaged model. The 
model-average results are presented in Table 2. The skew and kurtosis values of the residuals 
indicate that our average model met the linear regression model assumption of having 
normally-distributed residuals, skew = -0.48, kurtosis = 1.44. Breusch-Pagan test indicated no 
heterocedasticity in our average model, studentized Breusch-Pagan = 9.37, p = 0.59. Visual 
examination of the residuals vs leverage plot did not reveal any data points with unusually 
high leverage or influence. Overall, the predicted values from the average model shared 
9.17% variance with actual sexual dimorphism in men, r208 = 0.30, p < 0.001 indicating that 
immune function of men when they were 14 years old significantly predicted their facial 
masculinity at 22 years old. The relative importance values of the predictors, which were 
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calculated based on the sum of the ‘Akaike weights’ over all models that included that 
particular predictor, indicated that there were four important predictors, namely PC15, PC4, 
PC6, and PC9 (Table 2). Out of these four predictors, facial masculinity in men was 
positively and significantly predicted by immune PC15 and PC9, but only marginally by 
immune PC4 and PC6 (Table 2, Figure 3). These four immune PCs were loaded substantially 
by measures related to allergies (PC15, PC9, and PC4), antibacterial immunity (PC15 and 
PC6), and cellular immunity (PC15). To help visualise the facial differences between those 
high and low on the two immune PCs that significantly predicted facial masculinity, we 
presented the high-immune and low-immune average faces in Supplementary Figure 2. The 
high-immune average was created from a total of six faces, the top three faces on immune 
PC15 and the top three faces on immune PC9. The same was done for the low-immune 
average using the bottom three faces from each of the two PCs.   
 
Table 2. Model-averaged results of immune function PCs predicting men’s facial masculinity 
(N = 210) 












(Intercept) 97.35 7.59 12.75 < 0.001 82.38 112.31   
Immune PC 15 15.90 7.63 2.07 0.0383 0.85 30.95 0.15 1.00 
Immune PC 4 16.97 9.10 1.86 0.0636 -0.96 34.91 0.13 1.00 
Immune PC 6 23.57 12.44 1.88 0.0595 -0.95 48.09 0.13 1.00 
Immune PC 9 19.47 9.39 2.06 0.0393 0.95 37.98 0.15 0.88 
Immune PC 14 -11.98 8.86 1.34 0.1790 -29.46 5.49 0.10 0.42 
Immune PC 5 18.44 13.52 1.36 0.1751 -8.21 45.08 0.10 0.45 
Immune PC 10 -9.88 8.15 1.21 0.2283 -25.95 6.19 0.09 0.21 
Immune PC 8 -7.02 7.84 0.89 0.3733 -22.48 8.44 0.06 0.14 
Immune PC 13 -8.50 9.53 0.89 0.3756 -27.29 10.30 0.06 0.14 
Immune PC 11 5.79 8.03 0.72 0.4733 -10.04 21.62 0.05 0.08 




Figure 3. Partial effect plots of the immune PCs that predicted male facial masculinity. PC4 
and PC6 were only marginally significant.  
 
We checked the robustness of the male model results by testing whether any of the 
immune PCs were significantly correlated with pubertal developmental stage (measured 
based on the Tanner’s pubertal developmental stage classification scale). Immune function 
may be confounded by the immunosuppressive effects of testosterone as testosterone levels 
surge during puberty. None of the immune PCs were correlated with pubertal developmental 










































































stage, indicating that our results were not subject to confounds due to pubertal developmental 
stage. The statistics are presented in Supplementary Table 3. 
A previous study suggested that facial adiposity might account for the relationship 
between immune function and facial masculinity (Rantala et al., 2013). Therefore, we 
checked whether the immune PCs were correlated with body mass index of the male 
participants at 22 years (BMI), a correlate and proxy of facial adiposity (de Jager, Coetzee, & 
Coetzee, 2018), as well as the body measurements that constitute the BMI measure, namely 
weight and height at 22 years. None of the immune PCs were significantly correlated with 
BMI at 22 years (Supplementary Table 4). Immune PC 14 was positively correlated with 
height at 22 years (Supplementary Table 4). But the relationship did not survive Bonferroni 
corrections (Supplementary Table 4). We also note that immune PC 14 was not one of the 
predictors of facial masculinity (Table 2). We note that BMI does not distinguish between 
different sources of mass (fat, muscles, water, bones etc.). However, given that it is 
substantially correlated with facial adiposity (de Jager et al., 2018), the lack of a relationship 
between BMI and facial masculinity suggests that the relationship between immunity at 14 
years and facial masculinity at 22 years is unlikely to be associated with facial adiposity at 22 
years. The lack of a robust relationship with height and weight also indicates that immune 
function is unlikely to be related with sexual dimorphism in overall body (and face) size. 
 3.2 The relationship between immune function and facial femininity in women 
3.2.1 Female immune data reduction. PCA with varimax rotation was used to 
summarize the female immune data. The immune measure EPX was excluded from the PCAs 
and all subsequent analyses due to missing EPX data from 16 participants (6.78%). Sixteen 
PCs were retained (eigenvalue > 1), accounting for 73.90% of the total variance 
(Supplementary Table 5). The PCs were loaded by immune measures that measured similar 
 24 
aspects of the immune system or reactions to the same antigen, suggesting that our PCA 
succeeded at identifying clusters of related measures. 
3.2.2 Immune predictors of facial femininity in women. Visual examination of the 
scatterplots of facial femininity and each of the 16 immune PCs revealed similar outlier 
issues as in the men’s data on immune PCs 1, 2, 3, 5, 6, 7, 9, 10, 12, 13, 14, 15 
(Supplementary figure 3). Therefore, we winsorized all immune PCs to ±4SDs before 
conducting the model selection and averaging. The zero-order correlations between facial 
masculinity and each of the individual immune PCs after winsorization are presented in 
Supplementary Table 6. 
For the female data, 31 models, including the “best” model and 30 others that were 
within two AICc values from the “best” model, were selected from a total of 65535 models. 
The “best” model was 12.38 AICc points lower than the null model, AICcs = 2695.19“best” 
model vs 2707.57null model, indicating that even the least informative model that was selected 
was a better fit compared to the null model based on the criterion of two of more AICc points 
lower than the null (Burnham & Anderson, 2002). This result indicated that the averaged 
model was indeed more informative than the null model. Evidence ratios of the selected 
models relative to the null (i.e. how many times more likely the model results are relative to 
the null) ranged from 179.5 to 487.8.  
The model-average result is presented in Table 3. The skew and kurtosis values of the 
residuals indicate that the average model met the linear regression model assumption of 
having normally-distributed residuals, skew = 0.01, kurtosis = -0.08. Breusch-Pagan test 
indicated no heterocedasticity in our average model, studentized Breusch-Pagan = 19.25, p = 
0.08. Visual examination of the residuals vs leverage plot did not reveal any data points with 
unusually high leverage or influence. Overall, the predicted values from the average model 
shared 10.63% variance with actual facial femininity in women, r223 = 0.33, p < 0.001, 
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indicating that immune function of women when they were 13 years old significantly 
predicted their facial femininity at 22 years old. The relative importance values of the 
predictors, which were calculated based on the sum of the ‘Akaike weights’ over all models 
that included that particular predictor, indicated that there were five important predictors, 
namely PC13, PC15, PC3, PC4, and PC8 (Table 3). Out of these 5 predictors, female 
femininity was positively and significantly predicted by PC13 and negatively by PC15 (Table 
3, Figure 4). Although the regression coefficient for PC15 was negative, the immune 
measures that loaded substantially onto this PC were in the negative direction 
(Supplementary Table 4). Therefore, for both PC13 and PC15, the more feminine the face 
shape, the better the woman’s immunity. PC13 was loaded substantially by measures linked 
to allergic responses and PC15 by those linked to antibacterial immunity. The high-immune 
and low-immune average faces are presented in Supplementary Figure 4 using the top vs 
bottom three faces from each of the two PCs.   
 
Table 3. Model-averaged results of immune function PCs predicting women’s facial 
femininity (N = 225) 












(Intercept) 90.23 6.36 14.11 0.0000 77.70 102.76   
Immune PC 13 23.22 8.41 2.75 0.0061 6.64 39.80 0.19 1.00 
Immune PC 15 -18.55 7.29 2.53 0.0114 -32.90 -4.19 0.17 1.00 
Immune PC 3 -13.59 8.15 1.66 0.0972 -29.65 2.47 0.11 0.73 
Immune PC 4 10.92 6.36 1.71 0.0875 -1.60 23.44 0.12 0.77 
Immune PC 7 -14.58 9.54 1.52 0.1286 -33.39 4.22 0.10 0.56 
Immune PC 8 10.57 6.35 1.66 0.0979 -1.95 23.08 0.11 0.75 
Immune PC 9 -7.64 6.37 1.19 0.2331 -20.19 4.92 0.08 0.25 
Immune PC 14 -6.13 7.03 0.87 0.3862 -19.98 7.73 0.06 0.08 
Immune PC 16 -5.36 6.35 0.84 0.4010 -17.86 7.15 0.06 0.06 
Immune PC 1 -4.59 6.41 0.71 0.4770 -17.23 8.05 0.05 0.05 
Immune PC 10 -3.97 6.33 0.62 0.5327 -16.44 8.50 0.04 0.03 




Figure 4. Partial effect plots of the immune PCs that predicted female facial femininity.  
 
We checked the robustness of the model results by looking at whether any of the 
immune PCs were significantly correlated with the pubertal developmental stage of females. 
There were two separate Tanner’s pubertal developmental stage classifications for female 
pubertal developmental stage, one based on pubic hair development and the other on breast 
development. We summarize the two measures into a single PC (eigenvalue > 1) accounting 
for 67.10% of the total variance. None of the immune PCs were correlated with pubertal 
developmental stage, indicating that our results were not subject to confounds due to pubertal 
developmental stage (Supplementary Table 7).  
We also checked whether the immune PCs were correlated with the female 
participants’ BMI, weight, and height at 22 years. (Supplementary Table 8). Before 
Bonferroni corrections, there were several significant correlations, namely immune PC 10 
with BMI, height, and weight, PC 12 with height, and PC 13 with BMI. But none of these 
correlations survived Bonferroni corrections (Supplementary Table 8), indicating that none of 
them were robust. Given the lack of any significant relationships with BMI, the relationship 






















































between immune function at 14 years and facial femininity at 22 years in women is 
associated with facial adiposity at 22 years. The lack of a robust relationship with height and 
weight also indicates that immune function is unlikely to be related with sexual dimorphism 
in overall body (and face) size. 
4. Discussion 
The idea that individuals prefer more sexually dimorphic faces because facial sexual 
dimorphism indicates health, particularly immune function, is one of the most prominent 
theoretical frameworks in the study of human facial preferences (Little et al., 2011; Rhodes, 
2006; Thornhill & Gangestad, 1999). However, this framework has come under intense 
scrutiny because studies on the relationship between facial sexual dimorphism and current 
adult immune function have yielded mixed results (Cai et al., 2019; Foo, Simmons, et al., 
2017; Gray & Boothroyd, 2012; Phalane et al., 2017; Rantala et al., 2012; Rhodes et al., 
2003; Scott et al., 2013; Thornhill & Gangestad, 2006). Here, rather than testing current 
immune function, we used a longitudinal public health dataset to test the life-history 
prediction that individuals who had better immune function during adolescence should have 
more sexually dimorphic face shape as adults. As predicted, we found positive relationships 
between some aspects of immunity during adolescence and sexually dimorphic 3D face shape 
in adulthood in both men and women. For men, the immune PCs that positively predicted 
male facial masculinity included measures related to allergies, antibacterial immunity, and 
cellular immunity. For women, the immune PCs that positively predicted facial femininity 
included measures linked to allergic responses and antibacterial immunity. Our results 
support a fundamental theoretical assumption underlying studies on the evolutionary basis of 
facial sexual dimorphism preferences in humans: facial sexual dimorphism indicates immune 
health during development.  
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Our conclusions were supported by several observations. The evidence ratios derived 
from the AICc scores indicated that the selected models comprising our final averaged 
models were 19.9 to 54.1 times more likely than the null for men and 179.5 to 487.8 times for 
women, suggesting that immune function during early adolescence indeed predicts adult 
facial sexual dimorphism (based on the criterion of  >10x suggested by Burnham & 
Anderson, 2002). Our conclusions were further corroborated by the effect sizes of our final 
averaged models, which showed a medium effect size of r = 0.3 for both sexes (Cohen, 
1988). Our effect sizes were larger than those typically found in evolutionary biology studies, 
which range from r = 0.16 to 0.25 (Møller & Jennions, 2002). Therefore, the relationship 
between adolescent immune function and adult facial sexual dimorphism in both men and 
women may indeed be biologically relevant. We note that despite the medium overall model 
effect sizes, the independent contributions of individual immune PCs that significantly 
predicted facial sexual dimorphism in either sex were small, ranging from r = 0.15 to r = 
0.19. However, all of them were consistently in the positive direction predicted by theory for 
both sexes (higher masculinity for men and higher femininity for women – high immunity). 
Our results for men match those of Rhodes et al (2003), the only other study that has 
examined the developmental relationship between health and facial sexual dimorphism in 
humans. Similar to Rhodes et al (2003), we found that health during adolescence (immune 
function specifically in our case) positively predicted male facial masculinity. In contrast to 
their null findings for women, however, we found that immune function during adolescence 
also positively predicted female facial femininity. One notable methodological difference 
between the current study and Rhodes et al (2003) lies in the health measures used. Rhodes et 
al (2003) was based on doctors’ ratings of the participants’ medical records. Such ratings may 
reflect not just resistance to infections, but also other aspects of health such as reproductive 
or even mental health. In contrast, our health measures were based on objective physiological 
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markers of immunity. Therefore, using more direct measures of potential susceptibility to 
disease, we found positive relationships between immune function and facial sexual 
dimorphism in both sexes as predicted by life-history theory. 
Our findings for men were consistent with the immunocompetence handicap 
hypothesis, which suggests that facial masculinity is an honest indicator of men’s immune 
function during development due to the immunosuppressive effects of the male hormone 
testosterone (Folstad & Karter, 1992; Foo et al., 2017). However, it is unclear how the 
hypothesis would apply to our female results given that the effect of the female hormone 
estrogen on female immune function is mixed (Foo et al., 2017). Therefore, the relationship 
between immune function and facial femininity in women is likely to be explained by other 
mechanisms. Indeed, some researchers have proposed potential mechanisms mediating the 
relationship between attractive traits and immune function that do not invoke the involvement 
of sex hormones, including nutrition-mediated trade-offs (Sheldon & Verhulst, 1996) or 
trade-offs occurring simply due to increased reproductive investment (Rolff, 2002). 
Our findings also stand in contrast to those that have failed to find a relationship 
between facial masculinity in men and MHC heterozygosity (Lie et al., 2008), including a 
recent large-scale study based on more than 1000 men (Zaidi et al., 2019). These null 
findings have led to the argument that facial masculinity in men might not be condition-
dependent (Zaidi et al., 2019). However, MHC heterozygosity provides a genetic predictor of 
variation in one particular aspect of the adaptive immune system: the ability to recognize a 
diversity of antigens. It does not measure the actual ability of individuals to mount a 
phenotypic response to pathogens. Here, our direct phenotypic measures of immune function 
suggests that masculinity is actually dependent on a number of innate and adaptive aspects of 
the immune system. 
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The use of a comprehensive set of immune function measures is an important strength 
of the current study. The immune system is a highly complex collection of mechanisms that 
work in tandem to protect us against pathogens (Parkin & Cohen, 2001). Given its 
complexity, single measures are unlikely to represent overall immunity. Indeed, eco-
immunologists have recently cautioned against overgeneralizing findings derived from a 
small number of measures (Blount et al., 2003; Demas & Nelson, 2012; Møller & Petrie, 
2002; Norris & Evans, 2000). Here, our findings reiterate the need to include multiple facets 
of immunity when studying the immune system. For each sex, only two out of a total of 16 
immune PCs significantly predicted facial sexual dimorphism.  
The finding that some immune measures show links with other life-history traits while 
others do not is typical of the non-human animal literature (Blount et al., 2003; Demas & 
Nelson, 2012; Møller & Petrie, 2002; Norris & Evans, 2000). Several potential explanations 
have been proposed for such mixed results. One possibility is that life-history trade-offs 
between different branches of the immune system may prevent them from showing an 
elevated response simultaneously (Blount et al., 2003; Demas & Nelson, 2012; Moller & 
Petrie, 2002). For instance, multiple studies have demonstrated such trade-offs through 
negative correlations between different aspects of immunity in non-human animal species 
(Faivre et al., 2003; Johnsen & Zuk, 1999; Martin et al., 2006). Similarly, in humans, 
antibacterial/viral immunity vs allergies (i.e. Th1 vs Th2 immune classes) are mutually 
antagonistic (Kaiko, Horvat, Beagley, & Hansbro, 2008). Indeed, we observe such a trade-off 
in immune PC2 for women, where measures for antibacterial/viral immunity vs allergies are 
loaded in opposite directions. To better understand the evolutionary links between immune 
function and sexually selected traits, it is therefore necessary to employ a range of measures 
that index different aspects of immunity. We hope that the current study will encourage 
future studies to do so. 
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A second possibility is that sexually-selected traits might have evolved to indicate 
immune defence against certain pathogens encountered during a given species’ evolutionary 
history (Demas & Nelson, 2012; Hamilton & Zuk, 1982; Møller & Petrie, 2002; Norris & 
Evans, 2000). This explanation may account for the positive relationship between facial 
sexual dimorphism and allergies that we found for both men and women. Most of the 
immune measures in this study are linked to important protective processes, such as 
antibacterial immunity, cellular immunity, and inflammation (Parkin & Cohen, 2001). 
Allergies, however, are reactions to harmless particles, such as pollen or animal dander 
(Holgate, Church, Broide, & Martinez, 2012). In fact, they often lead to negative outcomes, 
ranging from mild irritations (e.g. having a runny nose) to potentially life-threatening 
reactions such as anaphylaxis (Holgate et al., 2012). So why has facial sexual dimorphism 
evolved to indicate heightened allergies in both sexes? One influential hypothesis regarding 
the evolutionary basis of the allergic response is that it represents an evolved mechanism for 
flushing out parasitic worms through increased production of fluids (weep) and increased 
muscular contractility (sweep)(Okada, Kuhn, Feillet, & Bach, 2010; Strachan, 1989). 
However, the eradication of parasitic worms in modern developed societies through better 
hygiene infrastructure has left this aspect of immune function without its original target, 
possibly leading it to misdirect its reactions to harmless particles (Okada et al., 2010; 
Strachan, 1989). Such an explanation may be particularly relevant to Caucasians, whose late-
stage evolution occurred in environments in which helminth parasite loads were much lower 
than those who continued in tropical/subtropical environments (e.g. Africans). Several lines 
of evidence demonstrate the link between allergic responses and the protective mechanisms 
against parasitic worms. Both responses are IgE-antibodies-mediated and allergic symptoms 
are reminiscent of the weep-and-sweep mechanisms for flushing out parasitic worms (hence 
the runny nose) (Anthony, Rutitzky, Urban, Stadecker, & Gause, 2007; Holgate et al., 2012; 
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Okada et al., 2010). The proteins in allergens and parasitic worms that trigger an immune 
response also share structural similarities (Tyagi et al., 2015). Epidemiological studies show 
that infections by parasitic worms are protective against allergies (Flohr et al., 2006), which 
is consistent with the hypothesis that allergies are misdirected responses of an idle defence 
mechanism. Given the links between allergic responses and the protective mechanisms 
against parasitic worms, it is possible that facial sexual dimorphism has its evolutionary 
origin in an indicator of protection against parasitic threats.  
We note four potential limitations/future directions for our study. First, our results were 
based on a search through 65535 models with 16 potential immune function PCs. Four PCs 
for men and two PCs for women were associated with facial sexual dimorphism. Given that 
an experimental approach to testing these associations would be impossible with human 
participants, future work should examine whether the relationships we have observed can be 
replicated with different cohorts of participants. On the other hand, although our dataset 
contains more than 40 different immune measures, it is by no means an exhaustive list 
(Parkin & Cohen, 2001). Therefore, future studies may find it fruitful to examine the 
developmental relationship between immune function and facial sexual dimorphism using 
other measures of immunity, such as the formation of adaptive responses to novel pathogens 
following vaccinations. Third, our immune measures were taken from a single time point. 
The adolescent developmental period can last up to 10 years or more (Sawyer, Azzopardi, 
Wickremarathne, & Patton, 2018). Therefore, measurements of immunity taken across 
multiple time points might provide more stable estimates of immunity during adolescence. 
Therefore, we might expect such aggregate measures from multiple time points to better 
predict adult facial sexual dimorphism than measures taken from a single time point. Fourth, 
it would also be interesting, as a future direction, to investigate whether the 3D faces of 
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individuals in our sample with better immunity are more attractive to the opposite sex than 
those with poorer immunity, as predicted by the theory of sexual signalling.  
In summary, our results showed that some aspects of immune function during early 
adolescence, the period in which much of our facial sexual dimorphism develops, positively 
predicted sexually dimorphic 3D face shape in both men and women. They support a 
relatively neglected yet fundamental assumption of life-history theory: that facial sexual 
dimorphism is attractive in humans partly because it indicates immune health during 
development. More broadly, they suggest that there might indeed be a biological basis to our 
preferences for facial sexual dimorphism in potential mating partners.  
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